US20100292685A1 - Recanalizing occluded vessels using radiofrequency energy - Google Patents
Recanalizing occluded vessels using radiofrequency energy Download PDFInfo
- Publication number
- US20100292685A1 US20100292685A1 US12/680,500 US68050008A US2010292685A1 US 20100292685 A1 US20100292685 A1 US 20100292685A1 US 68050008 A US68050008 A US 68050008A US 2010292685 A1 US2010292685 A1 US 2010292685A1
- Authority
- US
- United States
- Prior art keywords
- energy
- longitudinal member
- occlusion
- longitudinal
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
- A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
- A61B2018/1861—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves with an instrument inserted into a body lumen or cavity, e.g. a catheter
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Plasma & Fusion (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- This invention relates generally to dealing with occlusions of the lumen and more specifically to apparatus and methods for crossing severe or total chronic occlusions of lumens in the body using radiofrequency energy.
- Chronic total occlusion (CTO) is the complete blockage of a vessel and usually has serious consequences if not treated in a timely fashion. The blockage could be due to atheromatous plaque or old thrombus. One of the common procedures for treating CTOs of the coronary arteries is percutaneous transluminal coronary angioplasty (PTCA). During a PTCA procedure, a small incision is, typically, made in the groin. A guiding catheter over a guide wire is introduced into the femoral artery and advanced to the occlusion. Frequently, with gentle maneuvering, the guidewire is able to cross the occlusion. Then, a balloon-tipped angioplasty catheter is advanced over the guide wire to the occlusion. The balloon is inflated, separating or fracturing the atheroma. Some of the common steps involved in the PTCA procedure are the simultaneous injection of a contrast agent in the contra-lateral vessel, getting backup force or stabilization for a guide wire (which could invoke additional personnel to handle the catheter), puncturing the plaque, drilling or rotating the guide wire to push it through the dense plaque, etc. Because of the stiff resistance sometimes offered by dense plaque, one could be forced to use stiff wires. Occasionally, the wires could puncture the vessel wall calling for remedial measures.
- The most common percutaneous coronary intervention (PCI) failure mode for CTOs is inability to successfully pass a guidewire across the lesion into the true lumen of the distal vessel. To date, there is no consensus on how best to treat CTO after attempts with conventional guidewires have failed. Different strategies and specific devices for CTOs have been developed including the subintimal tracking and reentry with side branch technique, parallel wire technique, IVUS guided technique, retrograde approach, etc.
- Mechanical and energy based techniques have also been proposed for passing guidewires through hard calcified occlusions, such as mechanical cutting or oscillation and laser or ultrasound or radiofrequency (RF) energy ablation. Most of these devices work by locally applying energy at the tip of the guidewire or catheter device to cause ablation of the occlusion, which is carefully carried out to create a channel through the occlusion. Once a channel is created, the guidewire is used to guide the balloon catheter in place.
- RF energy is widely used to coagulate, cut or ablate tissue. In both modalities, monopolar and bipolar, conductive electrodes contact the tissue to be treated. In the monopolar mode, the active electrode is placed in contact with the tissue to be treated and a return electrode with a large surface area is located on the patient at a distance from the active electrode. In the bipolar mode, the active and return electrodes are in close proximity to each other bracketing the tissue to be treated. Sometimes an array of electrodes is used to provide better control over the depth of penetration of the RF field and hence control over the temperatures to which the tissue is heated. There are many disadvantages with each mode. For example, in the monopolar arrangement, because of the large physical separation between the electrodes there are frequent reports of local burning at the electrode sites. This would clearly be undesirable where one of the electrodes will be inside a blood vessel. The other serious issue is the likelihood of forming blood clots. The tissue that is in contact with the electrodes can be coagulated or ablated. In the case of the electrodes being present inside a blood vessel the chances of forming dangerous blood clots is quite high.
- In an attempt to overcome the issues described above, various device and electrode configurations are described in the following patents. U.S. Pat. Nos. 5,366,443 and 5,419,767 describe the use of RF electrodes on a catheter to cross a lesion. These patents describe a bipolar electrode assembly at the distal tip of a catheter that is in contact with the occlusion, and patentees claim that application of RF energy ablates the occlusion and renders the occlusion susceptible for the guidewire to penetrate. This method has the drawback that careful tracking of the occlusion and the ablation process is necessary to avoid trauma to the vessel walls or healthy tissue, since the possibility of short-circuiting of current through healthy tissue instead of the occlusion is high. U.S. Pat. No. 5,419,767 overcomes this limitation to a certain extent through the use of a multiple electrode array. However, this device requires a channel to be pre-created through the occlusion so that the device can be passed through a guidewire traversing this channel, which is not always easy.
- U.S. Pat. No. 5,514,128 to Hillsman et al. describes a laser catheter device that enables ablation of an occlusion in the vasculature. This system has similar drawbacks to the ones described above—need for a guidance system, potential for healthy tissue to be ablated, complexity (and hence cost) of the device, etc.
- One major problem with the existing devices is the potential for the ablation energy to damage the walls of the vasculature, in the absence of a mechanism to track the orientation and position of the energy delivery member. Several devices exist in the prior art that address the issue of tracking and steering of the energy delivery element. U.S. Pat. No. 6,911,026 to Hall et al. describes a magnetic steering and guidance system to direct an ablation device that delivers RF energy at the tip in a unipolar configuration where the return electrode is placed externally in contact with the body or in a bipolar configuration where the return electrode is a ring surrounding the central wire electrode.
- U.S. Pat. No. 6,416,523 to Lafontaine discusses a mechanical cutting device where the guidance is provided by measuring impedance of the tissue in contact. The guidance system senses the difference in impedance between the stenotic tissue and the vessel wall and directs the cutting element to the occlusion.
- However, none of these alternate strategies have provided satisfactory results for the most challenging of the CTOs. In case of hard calcified occlusions, the revascularization procedure can be tedious and time consuming. Therefore, there is a need for improved methods of ablating or disrupting the occlusive material that are safe, efficacious and fast. It would be beneficial to have alternate techniques and devices that would recanalize a CTO without the shortcomings of the current techniques.
- CTOs that are hard to recanalize, either because of the tortuous anatomy of the diseased vessel, or because the proximal end of the stenosis is too hard for the guide wire to penetrate, or other characteristics of the CTO that would make the standard procedure vulnerable to failure would benefit from newer approaches to recanalize CTOs. Recently a combined antegrade-retrograde approach has been proposed for recanalizing chronic occlusions (U.S. application Ser. No. 11/706,041). The method disclosed in the co-pending application would benefit from the use of energy for crossing CTOs.
- Various methods and devices are provided to overcome some of the commonly encountered problems in treating chronic total occlusions. One aspect of this invention is to provide a method and systems for successfully recanalizing an occluded vessel by advancing, in combination, guidewires in an antegrade and retrograde fashion to the occlusion and applying RF energy between the proximal and distal ends of the occlusion. The RF energy application across the occlusion is accomplished using a bipolar arrangement, where one electrode is located on the antegrade guidewire and the other electrode that makes up the bipolar arrangement is located on the retrograde guidewire.
- In one aspect, the present invention discloses a method of recanalizing an occluded vessel comprising advancing in an antegrade fashion a first longitudinal member through a proximal end of an occlusion, advancing in a retrograde fashion a second longitudinal member through a distal end of the occlusion, applying RF energy between the distal ends of the antegrade and retrograde guidewires, ablating the tissue locally, and creating a channel through which a guidewire could be advanced. In another embodiment, the retrograde guidewire could have a deployable capture mechanism at its distal end and upon deployment could snare the antegrade guidewire.
- In another aspect, this invention relates to a catheter assembly for recanalizing an occluded vessel comprising an antegrade longitudinal member with a distal end containing an RF electrode and a retrograde longitudinal member with a distal end containing a second RF electrode; and the proximal end of the catheter assembly connected to an RF generator. Additionally, a temperature measuring element could be disposed on the distal ends of the antegrade or retrograde longitudinal member. The RF generator could also be programmed to treat the tissue for a pre-set time or until a set condition has been reached. One such condition could be till the occlusion has reached a pre-determined temperature. Another condition could be the impedance of the occlusion.
- In another aspect, the invention is a kit for recanalizing occluded vessels comprising one or more of the following: an antegrade guidewire, a retrograde guidewire, a dilating device, a capture device and an injection catheter, wherein at least one of these devices contains at least one electrode. Additionally, the proximal ends of this device are configured to be coupled with an RF generator.
- Other aspects of the invention include methods corresponding to the devices and systems described above.
- The invention has other advantages and features which will be more readily apparent from the following detailed description of the invention and the appended claims, when taken in conjunction with the accompanying drawings, in which:
-
FIG. 1 is a schematic showing an RF generator connected to the longitudinal members. -
FIG. 2 shows the features of the longitudinal members. -
FIGS. 3A and 3B show the steps involved in recanalizing a CTO using bipolar RF and combined antegrade and retrograde approach. -
FIG. 4 shows an example embodiment of a longitudinal member comprising an embolic protection mechanism. -
FIGS. 5A-C show a longitudinal member structurally configured along at least part of the length of the catheter to enable advancement or alignment of the longitudinal member through a narrow diameter blood vessel or occlusion. - Although the detailed description contains many specifics, these should not be construed as limiting the scope of the invention but merely as illustrating different examples and aspects of the invention. It should be appreciated that the scope of the invention includes other embodiments not discussed in detail above. Various other modifications, changes and variations which will be apparent to those skilled in the art may be made in the arrangement, operation and details of the method and apparatus of the present invention disclosed herein without departing from the spirit and scope of the invention as described here.
- The present embodiments combine the use of RF energy delivered through antegrade and retrograde members for recanalizing occluded lumens, particularly chronic total occlusions. The methods and systems described herein recanalize difficult to cross occlusions by taking advantage of an antegrade and retrograde approach to establish a bipolar electrode arrangement across the occlusion. This approach minimizes the potential of the vessel wall becoming perforated or injured, as may otherwise occur in a conventional bipolar RF treatment approach, where both RF electrodes are on the same side of the occlusion. Because the electrodes are distributed on opposite sides of the occlusion, the tissue that is ablated by the RF treatment (i.e., the occlusion) is well contained between the electrodes. This also allows the user to localize the treatment to the occlusion.
- As disclosed in the co-pending U.S. patent application Ser. No. 11/706,041 by the same inventors, which is incorporated herein in its entirety, in the controlled antegrade and retrograde tracking (CART) technique the retrograde approach takes advantage of an intercoronary channel. Such a channel may be an epicardial channel, an inter-atrial channel, an intra-septal channel (also referred to as septal collateral), or a bypass graft. The basic concept of the CART technique is to create a channel through an occlusion, preferably with limited dissections, by approaching the occlusion both antegradely and retrogradely.
- While the combined antegrade and retrograde approach has been effective in crossing difficult to cross lesions, it has been observed that using energy, for example RF energy, to ablate or alter the tissue in a controlled fashion is beneficial in crossing hard to cross lesions. Such controlled energy deployment is achieved using a bipolar arrangement of the electrodes, where one electrode is located on the antegrade element and the other electrode that constitutes the bipolar arrangement is located on the retrograde element. These electrodes can also be referred to as the return and active electrodes. They are also referred to as the anode and cathode, respectively. The electrodes could also be arranged in an array (multiple electrodes), where the electrode arrangement provides better control over the depth of penetration of the RF field and thereby provides the ability to control the tissue temperature.
-
FIG. 1 shows a system for recanalizing occluded vessels using RF energy. The system compriseslongitudinal members FIG. 1 ,longitudinal member 100 a serves as an antegrade member andlongitudinal member 100 b serves as a retrograde member. An RF generator 10 (also referred to as a controller) serves as the source of RF energy to be provided tolongitudinal members Longitudinal members longitudinal members longitudinal member - To provide RF energy from the
RF generator 10 to theguidewires pigtail 20 connects at its proximal end to theRF generator 10 and terminates at its distal end in aconnector 30.Connector 30 is a standard connector that couples the input and output signals of theRF generator 10 to theguidewires -
Guidewires - As shown in
FIG. 2 , the antegrade andretrograde guidewires conductive electrodes electrodes respective guidewires - Conductive wires (not shown) connect the
electrodes connector 30 to deliver RF energy from theRF generator 10 to theelectrodes 105 a and 105. The exterior of the guidewires are covered bynon-conductive layers non-conductive layers - In one embodiment, and as further shown in
FIG. 2 , theguidewires temperature measuring elements temperature measuring elements connector 30. In another embodiment, pressure measuring elements are placed on the distal ends of the guidewires to detect a change in pressure upon activation of the RF energy. -
RF generator 10 is configured to allow the user to set a maximum temperature, a treatment time period, a level of RF power, or a combination of these control parameters. The treatment time period indicates the period of time over which the RF energy will flow between the electrodes. The maximum temperature setting serves as a threshold temperature for the tissue that is in contact with the electrodes, and theRF generator 10 can be set to reduce or shut off power to one or both electrodes when one or more of thetemperature measuring elements - In one embodiment, the
generator 10 is capable of measuring the impedance of the tissue between the twoelectrodes - The sequence of the recanalization treatment steps are illustrated in
FIGS. 3A and 3B . As shown in diagram A ofFIG. 3A , theantegrade guidewire 100 a andretrograde guidewire 100 b are advanced to the proximal anddistal ends occlusion 310, respectively. This can be accomplished using standard angioplasty techniques. As described in the above referenced co-pending U.S. patent application Ser. No. 11/706,041, the retrograde guidewire can be advanced to the distal end of theocclusion 310 b using collaterals such as the septals. - Once the user has confirmed that the
guidewires occlusion 310 and are not touching thevessel wall 300, the RF treatment is initiated. Alternatively, the guidewires are advanced as deep into the occlusion as possible to minimize the distance between the electrodes and, consequently, minimize the length of the ablation zone. Confirmation that theguidewires calcified occlusion 310 generally exhibits significantly higher impedance than thevessel wall 300. If an impedance measurement indicates a low impedance value, it is likely that one or both guidewires are in contact with thevessel wall 300, and appropriate repositioning of the guidewires may be warranted. - Upon initiating the recanalization RF treatment, the
occlusion 310 is ablated from theends occlusion 310 to the interior of theocclusion 310, as shown inFIG. 3A diagram B. The user then slowly and carefully advances one or bothguidewires occlusion 310, as shown inFIG. 3A diagram C. As shown inFIG. 3A , theantegrade guidewire 100 a may be kept stationary and theretrograde guidewire 100 b may be advanced through theocclusion 310. Once a channel has been created, theretrograde guidewire 100 b may be withdrawn and theantegrade guidewire 100 a may be advanced through theocclusion 310, as shown inFIG. 3A diagram D, and standard interventional procedures, such as balloon angioplasty, can be performed. Alternatively, theretrograde guidewire 100 b can be kept stationary during the RF treatment and theantegrade guidewire 100 a can be advanced through theocclusion 310. This is illustrated inFIG. 3B diagrams A-D. - Optionally, the catheter comprises a means for removing or withdrawing debris resulting from the RE ablation. For example, a mechanism could be provided to capture and retrieve the debris, or a suction device could be provided to actively remove the debris near the ablation area. Examples of such embolic protection mechanisms are disclosed in the above referenced co-pending U.S. patent application Ser. No. 11/706,041.
FIG. 4 shows an example embodiment of alongitudinal member 400 comprising anembolic protection mechanism 410. Theembolic protection mechanism 410 comprises filter, mesh, net, or similar element, for capturing and retrieving ablation debris. As another example, the embolic protection may comprise a balloon for occluding the vessel and preventing the debris from circulating, and for subsequent aspiration of the debris through a longitudinal member. As another example, if a sheath is provided, such sheath may also be configured to be or to include a debris capture and retrieval mechanism or a suction device. In one embodiment, a longitudinal member may be retracted, and the remaining sheath may be used as a capture and retrieval mechanism or a suction device to remove ablation debris. In another embodiment, the longitudinal member comprises an ablating wire housed in the lumen of a dilating catheter. Upon ablation, the ablating wire may be retracted and the dilating catheter may be used to remove the debris. Alternatively, the system comprises a separate catheter to provide suction, or otherwise capture and remove the debris from the ablation site. - Optionally, the device may be coupled to an electrocardiogram (EKG) machine to aid in timing energy emissions. For example, the rate of blood flow through the coronary arteries typically varies during the cardiac cycle. During systole when the heart is contracting, flow through the arteries is generally lower than during diastole. In one embodiment, energy emission is timed during diastole, for example using an algorithm to detect the R-wave of an EKG, and energy emission is timed to occur when flow is highest, thereby maximizing the cooling effect provided by blood flow and consequently minimizing the heat exposure to the vessel. Additionally, coronary artery dimensions can vary during the cardiac cycle and energy emission can similarly be timed to take advantage of this fact.
- Optionally, the device comprises a mechanism for detecting or estimating the distance between the electrodes, and for decreasing the amount of delivered RF energy as the distance between the electrodes decreases, thereby minimizing potential RF injury to the vessel wall.
- In another embodiment, the device is an ablation catheter comprising a longitudinal member having a distal end, a proximal end, and a guidewire shaft there-between comprising a guidewire lumen. The longitudinal member is a dilating catheter and is structurally configured along at least part of the length of the catheter to enable advancement or alignment of the longitudinal member through a narrow diameter blood vessel or occlusion. Advancement is achieved, for example, by turning or twisting the longitudinal member.
FIGS. 5A-C show such an embodiment of the present invention. For example, as shown inFIG. 5A , thelongitudinal member 500 may comprise ahelical exterior 501 that advances through the vessel and dilates the vessel as the member is being twisted or rotated.Helical exterior 501 comprises a plurality ofgrooves 502 carved into the outer body of thelongitudinal member 500. The distal tip oflongitudinal member 500 optionally comprises aradiopaque marker 510. Anelectrode 520 is located at or near the distal end of the catheter. Another example is shown inFIG. 5B , the cross section of which is shown inFIG. 5C . Thelongitudinal member 550 may comprise a plurality ofwires liner 565. In one embodiment, thewires Longitudinal member 550 optionally terminates at amarker 570. Anelectrode 580 is located at or near the distal end of thelongitudinal member 550. The ablation catheter additionally and optionally comprises conductive wires for transmitting energy between the electrode and an external energy source. Alternatively, the plurality of wires may be configured to act as the electrode or conductive wires. Additionally and optionally, the catheter comprises an insulatingsheath 560 which is optionally retractable. - The guidewires and electrodes may be made from any one or more suitable materials as is commonly known in the art. Examples of such suitable materials include stainless steel, Nitinol, Elgiloy, platinum, iridium, tantalum, titanium, cobalt, chromium, or any combinations thereof. In one embodiment, one or more of the guidewires may be made of a polymer, with an electrically conductive core for transmitting electrical energy to the respective electrodes.
- While the above embodiments refer to the use of RF energy for the purpose of ablation, it should be noted that other energy modalities may be used as well, for example ultrasound energy. In one embodiment, one or more longitudinal members of the recanalization systems of the present invention comprise one or more ultrasound transducers, instead of or in addition to RF electrodes. The ultrasound transducers provide ultrasound energy for ablating an occlusion. In one embodiment, both the antegrade and the retrograde longitudinal members comprise ultrasound transducers and ablate the lesion from an antegrade as well as a retrograde direction. Other energy modalities could include microwave and laser.
- It should be noted that the combined antegrade and retrograde energy delivery techniques described above could also be used as an adjunct technique to crossing CTOs in combination with using conventional methods. The technique could be used to sufficiently soften or weaken the occlusion, thereby allowing a guidewire or catheter to cross the occlusion.
- While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Claims (28)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/680,500 US8911435B2 (en) | 2007-09-26 | 2008-09-23 | Recanalizing occluded vessels using radiofrequency energy |
US12/753,844 US9283034B2 (en) | 2007-09-26 | 2010-04-02 | Recanalization system using radiofrequency energy |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97547307P | 2007-09-26 | 2007-09-26 | |
US12/680,500 US8911435B2 (en) | 2007-09-26 | 2008-09-23 | Recanalizing occluded vessels using radiofrequency energy |
PCT/US2008/077403 WO2009042614A1 (en) | 2007-09-26 | 2008-09-23 | Recanalizing occluded vessels using radiofrequency energy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/077403 A-371-Of-International WO2009042614A1 (en) | 2007-09-26 | 2008-09-23 | Recanalizing occluded vessels using radiofrequency energy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/753,844 Continuation-In-Part US9283034B2 (en) | 2007-09-26 | 2010-04-02 | Recanalization system using radiofrequency energy |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100292685A1 true US20100292685A1 (en) | 2010-11-18 |
US8911435B2 US8911435B2 (en) | 2014-12-16 |
Family
ID=40511823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/680,500 Active 2032-01-12 US8911435B2 (en) | 2007-09-26 | 2008-09-23 | Recanalizing occluded vessels using radiofrequency energy |
Country Status (7)
Country | Link |
---|---|
US (1) | US8911435B2 (en) |
EP (2) | EP2197383B1 (en) |
JP (4) | JP5618332B2 (en) |
KR (1) | KR101228879B1 (en) |
AU (1) | AU2008304599B2 (en) |
CA (2) | CA3024053C (en) |
WO (1) | WO2009042614A1 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080306499A1 (en) * | 2006-02-13 | 2008-12-11 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20100256616A1 (en) * | 2007-09-26 | 2010-10-07 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US20110166591A1 (en) * | 2006-02-13 | 2011-07-07 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
WO2013013248A2 (en) * | 2011-07-20 | 2013-01-24 | Retrovascular, Inc. | Energy facilitated composition delivery |
US8690818B2 (en) | 1997-05-01 | 2014-04-08 | Ekos Corporation | Ultrasound catheter for providing a therapeutic effect to a vessel of a body |
US8696612B2 (en) | 2001-12-03 | 2014-04-15 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US8740835B2 (en) | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US8764700B2 (en) | 1998-06-29 | 2014-07-01 | Ekos Corporation | Sheath for use with an ultrasound element |
US8852166B1 (en) | 2002-04-01 | 2014-10-07 | Ekos Corporation | Ultrasonic catheter power control |
US8911435B2 (en) | 2007-09-26 | 2014-12-16 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US9017323B2 (en) | 2010-11-16 | 2015-04-28 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US9044568B2 (en) | 2007-06-22 | 2015-06-02 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US9107590B2 (en) | 2004-01-29 | 2015-08-18 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US9486276B2 (en) | 2012-10-11 | 2016-11-08 | Tva Medical, Inc. | Devices and methods for fistula formation |
US9579494B2 (en) | 2013-03-14 | 2017-02-28 | Ekos Corporation | Method and apparatus for drug delivery to a target site |
US9849273B2 (en) | 2009-07-03 | 2017-12-26 | Ekos Corporation | Power parameters for ultrasonic catheter |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
US10188410B2 (en) | 2007-01-08 | 2019-01-29 | Ekos Corporation | Power parameters for ultrasonic catheter |
US10232196B2 (en) | 2006-04-24 | 2019-03-19 | Ekos Corporation | Ultrasound therapy system |
US10603040B1 (en) | 2015-02-09 | 2020-03-31 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US10646666B2 (en) | 2014-08-27 | 2020-05-12 | Tva Medical, Inc. | Cryolipolysis devices and methods therefor |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US10695534B2 (en) | 2014-03-14 | 2020-06-30 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
CN111712280A (en) * | 2017-12-21 | 2020-09-25 | 赛诺菲 | Transmission of data relating to use of an injection device using passive RF modulation |
US10821217B2 (en) | 2013-03-14 | 2020-11-03 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10874422B2 (en) | 2016-01-15 | 2020-12-29 | Tva Medical, Inc. | Systems and methods for increasing blood flow |
US10888657B2 (en) | 2010-08-27 | 2021-01-12 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US11026743B2 (en) | 2016-01-15 | 2021-06-08 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11285028B2 (en) | 2016-09-25 | 2022-03-29 | Tva Medical, Inc. | Vascular stent devices and methods |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
US11590322B2 (en) | 2016-01-15 | 2023-02-28 | Tva Medical, Inc. | Devices and methods for advancing a wire |
US11865312B2 (en) | 2017-12-21 | 2024-01-09 | Sanofi | RFID dose tracking mechanism for injection devices |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561073B2 (en) | 2007-09-26 | 2017-02-07 | Retrovascular, Inc. | Energy facilitated composition delivery |
US9084620B2 (en) * | 2013-03-14 | 2015-07-21 | DePuy Synthes Products, Inc. | Detection and clearing of occlusions in catheters |
DE102015117171B4 (en) | 2014-10-09 | 2019-03-21 | Denso Corporation | BATTERIEZUSTANDSABSCHÄTZVORRICHTUNG |
WO2020183534A1 (en) * | 2019-03-08 | 2020-09-17 | オリンパス株式会社 | Vascular endoscope device and vascular endoscope system |
Citations (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US5041109A (en) * | 1986-10-27 | 1991-08-20 | University Of Florida | Laser apparatus for the recanalization of vessels and the treatment of other cardiac conditions |
US5188635A (en) * | 1988-02-08 | 1993-02-23 | Wolfgang Radtke | Catheter for percutaneous surgery of blood vessels and organs using radiant energy |
US5366443A (en) * | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US5419767A (en) * | 1992-01-07 | 1995-05-30 | Thapliyal And Eggers Partners | Methods and apparatus for advancing catheters through severely occluded body lumens |
US5501694A (en) * | 1992-11-13 | 1996-03-26 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5514128A (en) * | 1992-08-18 | 1996-05-07 | Spectranetics Corporation | Fiber optic guide wire and support catheter therefor |
US5624430A (en) * | 1994-11-28 | 1997-04-29 | Eton; Darwin | Magnetic device to assist transcorporeal guidewire placement |
US5695517A (en) * | 1994-02-10 | 1997-12-09 | Endovascular Systems, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
US5851185A (en) * | 1997-07-02 | 1998-12-22 | Cabot Technology Corporation | Apparatus for alignment of tubular organs |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6068645A (en) * | 1999-06-07 | 2000-05-30 | Tu; Hosheng | Filter system and methods for removing blood clots and biological material |
US6068648A (en) * | 1998-01-26 | 2000-05-30 | Orthodyne, Inc. | Tissue anchoring system and method |
US6235044B1 (en) * | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6416523B1 (en) * | 2000-10-03 | 2002-07-09 | Scimed Life Systems, Inc. | Method and apparatus for creating channels through vascular total occlusions |
US6454775B1 (en) * | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
US20030028200A1 (en) * | 1998-11-06 | 2003-02-06 | St. Jude Medical Atg, Inc. | Minimally invasive revascularization apparatus and methods |
US20030065316A1 (en) * | 1998-07-22 | 2003-04-03 | Marc-Alan Levine | Flexible flow apparatus and method for the disruption of occlusions |
US6697863B1 (en) * | 1998-09-03 | 2004-02-24 | Nec Corporation | Method and packet-processing device for use in an active node included in an active network to allocate a sequence of packets received by the active node |
US20040230219A1 (en) * | 2003-05-12 | 2004-11-18 | Roucher Leo R. | Anchoring, supporting and centering catheter system for treating chronic total occlusions |
US6911026B1 (en) * | 1999-07-12 | 2005-06-28 | Stereotaxis, Inc. | Magnetically guided atherectomy |
US20050154400A1 (en) * | 2003-12-18 | 2005-07-14 | Asahi Intecc Co., Ltd | Medical treating tool |
US20050171478A1 (en) * | 1998-01-13 | 2005-08-04 | Selmon Matthew R. | Catheter system for crossing total occlusions in vasculature |
US6936056B2 (en) * | 1996-07-26 | 2005-08-30 | Kensey Nash Corporation | Intravascular system for occluded blood vessels and guidewire for use therein |
US20060079880A1 (en) * | 2004-10-13 | 2006-04-13 | Sage Shahn S | Transurethral needle ablation system with flexible catheter tip |
US7037316B2 (en) * | 1997-07-24 | 2006-05-02 | Mcguckin Jr James F | Rotational thrombectomy device |
US20060224112A1 (en) * | 2005-04-04 | 2006-10-05 | Cook Incorporated | Scored catheter device |
US20070043389A1 (en) * | 2005-08-05 | 2007-02-22 | Shintech, Llc | System for treating chronic total occlusion caused by lower extremity arterial disease |
US20070112342A1 (en) * | 2001-05-10 | 2007-05-17 | Rita Medical Systems, Inc. | Tissue ablation apparatus and method |
US20070173878A1 (en) * | 2006-01-25 | 2007-07-26 | Heuser Richard R | Catheter system for connecting adjacent blood vessels |
US20070208368A1 (en) * | 2006-02-13 | 2007-09-06 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20070293846A1 (en) * | 2006-04-21 | 2007-12-20 | Abbott Laboratories | Dual Lumen Guidewire Support Catheter |
US20080039935A1 (en) * | 2006-08-14 | 2008-02-14 | Wally Buch | Methods and apparatus for mitral valve repair |
US20080039830A1 (en) * | 2006-08-14 | 2008-02-14 | Munger Gareth T | Method and Apparatus for Ablative Recanalization of Blocked Vasculature |
US20080154153A1 (en) * | 2004-08-25 | 2008-06-26 | Heuser Richard R | Multiple-wire systems and methods for ablation of occlusions within blood vessels |
US20080306499A1 (en) * | 2006-02-13 | 2008-12-11 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20080312673A1 (en) * | 2007-06-05 | 2008-12-18 | Viswanathan Raju R | Method and apparatus for CTO crossing |
US20100256616A1 (en) * | 2007-09-26 | 2010-10-07 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US20130072957A1 (en) * | 2011-09-19 | 2013-03-21 | Boston Scientific Scimed, Inc. | Subintimal re-entry catheter and retrograde recanalization |
US8545418B2 (en) * | 2004-08-25 | 2013-10-01 | Richard R. Heuser | Systems and methods for ablation of occlusions within blood vessels |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4998933A (en) * | 1988-06-10 | 1991-03-12 | Advanced Angioplasty Products, Inc. | Thermal angioplasty catheter and method |
US5749914A (en) * | 1989-01-06 | 1998-05-12 | Advanced Coronary Intervention | Catheter for obstructed stent |
US5324255A (en) * | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
JPH0698937A (en) * | 1992-09-18 | 1994-04-12 | Inter Noba Kk | Hot balloon catheter |
JPH06125915A (en) * | 1992-10-21 | 1994-05-10 | Inter Noba Kk | Catheter type medical instrument |
DE69432148T2 (en) * | 1993-07-01 | 2003-10-16 | Boston Scient Ltd | CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION |
JPH0956825A (en) * | 1995-08-24 | 1997-03-04 | Nissho Corp | Hot balloon catheter |
JPH09135908A (en) * | 1995-11-17 | 1997-05-27 | Aloka Co Ltd | Ultrasonic diagnosis treatment system |
US5882329A (en) * | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
WO1998056324A1 (en) * | 1997-06-13 | 1998-12-17 | Arthrocare Corporation | Electrosurgical systems and methods for recanalization of occluded body lumens |
US6068688A (en) | 1997-11-12 | 2000-05-30 | Cabot Corporation | Particle having an attached stable free radical and methods of making the same |
US6241744B1 (en) | 1998-08-14 | 2001-06-05 | Fox Hollow Technologies, Inc. | Apparatus for deploying a guidewire across a complex lesion |
US6394956B1 (en) * | 2000-02-29 | 2002-05-28 | Scimed Life Systems, Inc. | RF ablation and ultrasound catheter for crossing chronic total occlusions |
US6554827B2 (en) | 2000-12-11 | 2003-04-29 | Scimed Life Systems, Inc. | Radio frequency ablation system |
EP1684655A2 (en) * | 2003-11-18 | 2006-08-02 | SciMed Life Systems, Inc. | System and method for tissue ablation |
US7704249B2 (en) * | 2004-05-07 | 2010-04-27 | Arthrocare Corporation | Apparatus and methods for electrosurgical ablation and resection of target tissue |
US8007440B2 (en) * | 2005-02-08 | 2011-08-30 | Volcano Corporation | Apparatus and methods for low-cost intravascular ultrasound imaging and for crossing severe vascular occlusions |
CA2612679A1 (en) * | 2005-06-20 | 2007-01-04 | Richardo D. Roman | Ablation catheter |
CA3024053C (en) | 2007-09-26 | 2021-12-07 | Osamu Katoh | Energy delivery and imaging catheter |
-
2008
- 2008-09-23 CA CA3024053A patent/CA3024053C/en active Active
- 2008-09-23 WO PCT/US2008/077403 patent/WO2009042614A1/en active Application Filing
- 2008-09-23 US US12/680,500 patent/US8911435B2/en active Active
- 2008-09-23 JP JP2010527088A patent/JP5618332B2/en active Active
- 2008-09-23 EP EP08834456.9A patent/EP2197383B1/en active Active
- 2008-09-23 KR KR1020107008803A patent/KR101228879B1/en active IP Right Grant
- 2008-09-23 AU AU2008304599A patent/AU2008304599B2/en active Active
- 2008-09-23 EP EP18154292.9A patent/EP3348221A1/en active Pending
- 2008-09-23 CA CA2700968A patent/CA2700968C/en active Active
-
2014
- 2014-06-17 JP JP2014124232A patent/JP6050283B2/en active Active
-
2016
- 2016-11-24 JP JP2016227657A patent/JP6461891B2/en active Active
-
2018
- 2018-12-25 JP JP2018240919A patent/JP6785832B2/en active Active
Patent Citations (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US5041109A (en) * | 1986-10-27 | 1991-08-20 | University Of Florida | Laser apparatus for the recanalization of vessels and the treatment of other cardiac conditions |
US5188635A (en) * | 1988-02-08 | 1993-02-23 | Wolfgang Radtke | Catheter for percutaneous surgery of blood vessels and organs using radiant energy |
US5366443A (en) * | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US5419767A (en) * | 1992-01-07 | 1995-05-30 | Thapliyal And Eggers Partners | Methods and apparatus for advancing catheters through severely occluded body lumens |
US5514128A (en) * | 1992-08-18 | 1996-05-07 | Spectranetics Corporation | Fiber optic guide wire and support catheter therefor |
US5501694A (en) * | 1992-11-13 | 1996-03-26 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5695517A (en) * | 1994-02-10 | 1997-12-09 | Endovascular Systems, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
US5624430A (en) * | 1994-11-28 | 1997-04-29 | Eton; Darwin | Magnetic device to assist transcorporeal guidewire placement |
US5895398A (en) * | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6936056B2 (en) * | 1996-07-26 | 2005-08-30 | Kensey Nash Corporation | Intravascular system for occluded blood vessels and guidewire for use therein |
US5851185A (en) * | 1997-07-02 | 1998-12-22 | Cabot Technology Corporation | Apparatus for alignment of tubular organs |
US7037316B2 (en) * | 1997-07-24 | 2006-05-02 | Mcguckin Jr James F | Rotational thrombectomy device |
US20050171478A1 (en) * | 1998-01-13 | 2005-08-04 | Selmon Matthew R. | Catheter system for crossing total occlusions in vasculature |
US6068648A (en) * | 1998-01-26 | 2000-05-30 | Orthodyne, Inc. | Tissue anchoring system and method |
US20030065316A1 (en) * | 1998-07-22 | 2003-04-03 | Marc-Alan Levine | Flexible flow apparatus and method for the disruption of occlusions |
US6697863B1 (en) * | 1998-09-03 | 2004-02-24 | Nec Corporation | Method and packet-processing device for use in an active node included in an active network to allocate a sequence of packets received by the active node |
US20030028200A1 (en) * | 1998-11-06 | 2003-02-06 | St. Jude Medical Atg, Inc. | Minimally invasive revascularization apparatus and methods |
US6068645A (en) * | 1999-06-07 | 2000-05-30 | Tu; Hosheng | Filter system and methods for removing blood clots and biological material |
US6911026B1 (en) * | 1999-07-12 | 2005-06-28 | Stereotaxis, Inc. | Magnetically guided atherectomy |
US6235044B1 (en) * | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6454775B1 (en) * | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
US20040082962A1 (en) * | 1999-12-06 | 2004-04-29 | Bacchus Vascular, Inc. | Systems and methods for clot disruption and retrieval |
US6416523B1 (en) * | 2000-10-03 | 2002-07-09 | Scimed Life Systems, Inc. | Method and apparatus for creating channels through vascular total occlusions |
US20070112342A1 (en) * | 2001-05-10 | 2007-05-17 | Rita Medical Systems, Inc. | Tissue ablation apparatus and method |
US20040230219A1 (en) * | 2003-05-12 | 2004-11-18 | Roucher Leo R. | Anchoring, supporting and centering catheter system for treating chronic total occlusions |
US20050154400A1 (en) * | 2003-12-18 | 2005-07-14 | Asahi Intecc Co., Ltd | Medical treating tool |
US20080154153A1 (en) * | 2004-08-25 | 2008-06-26 | Heuser Richard R | Multiple-wire systems and methods for ablation of occlusions within blood vessels |
US8545418B2 (en) * | 2004-08-25 | 2013-10-01 | Richard R. Heuser | Systems and methods for ablation of occlusions within blood vessels |
US20060079880A1 (en) * | 2004-10-13 | 2006-04-13 | Sage Shahn S | Transurethral needle ablation system with flexible catheter tip |
US20060224112A1 (en) * | 2005-04-04 | 2006-10-05 | Cook Incorporated | Scored catheter device |
US20070043389A1 (en) * | 2005-08-05 | 2007-02-22 | Shintech, Llc | System for treating chronic total occlusion caused by lower extremity arterial disease |
US20070049867A1 (en) * | 2005-08-05 | 2007-03-01 | Shindelman Larry E | System for treating chronic total occlusion caused by lower extremity arterial disease |
US20070173878A1 (en) * | 2006-01-25 | 2007-07-26 | Heuser Richard R | Catheter system for connecting adjacent blood vessels |
US20080306499A1 (en) * | 2006-02-13 | 2008-12-11 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20070208368A1 (en) * | 2006-02-13 | 2007-09-06 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20070293846A1 (en) * | 2006-04-21 | 2007-12-20 | Abbott Laboratories | Dual Lumen Guidewire Support Catheter |
US20080039830A1 (en) * | 2006-08-14 | 2008-02-14 | Munger Gareth T | Method and Apparatus for Ablative Recanalization of Blocked Vasculature |
US20080039935A1 (en) * | 2006-08-14 | 2008-02-14 | Wally Buch | Methods and apparatus for mitral valve repair |
US20080312673A1 (en) * | 2007-06-05 | 2008-12-18 | Viswanathan Raju R | Method and apparatus for CTO crossing |
US20100256616A1 (en) * | 2007-09-26 | 2010-10-07 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US20130072957A1 (en) * | 2011-09-19 | 2013-03-21 | Boston Scientific Scimed, Inc. | Subintimal re-entry catheter and retrograde recanalization |
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8690818B2 (en) | 1997-05-01 | 2014-04-08 | Ekos Corporation | Ultrasound catheter for providing a therapeutic effect to a vessel of a body |
US8764700B2 (en) | 1998-06-29 | 2014-07-01 | Ekos Corporation | Sheath for use with an ultrasound element |
US8696612B2 (en) | 2001-12-03 | 2014-04-15 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10926074B2 (en) | 2001-12-03 | 2021-02-23 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10080878B2 (en) | 2001-12-03 | 2018-09-25 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US9415242B2 (en) | 2001-12-03 | 2016-08-16 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US8852166B1 (en) | 2002-04-01 | 2014-10-07 | Ekos Corporation | Ultrasonic catheter power control |
US9943675B1 (en) | 2002-04-01 | 2018-04-17 | Ekos Corporation | Ultrasonic catheter power control |
US9107590B2 (en) | 2004-01-29 | 2015-08-18 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US10531884B2 (en) | 2006-02-13 | 2020-01-14 | Asahi Medical Technologies, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20110166591A1 (en) * | 2006-02-13 | 2011-07-07 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US9119651B2 (en) | 2006-02-13 | 2015-09-01 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20080306499A1 (en) * | 2006-02-13 | 2008-12-11 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US10232196B2 (en) | 2006-04-24 | 2019-03-19 | Ekos Corporation | Ultrasound therapy system |
US11058901B2 (en) | 2006-04-24 | 2021-07-13 | Ekos Corporation | Ultrasound therapy system |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
US10188410B2 (en) | 2007-01-08 | 2019-01-29 | Ekos Corporation | Power parameters for ultrasonic catheter |
US11925367B2 (en) | 2007-01-08 | 2024-03-12 | Ekos Corporation | Power parameters for ultrasonic catheter |
US11672553B2 (en) | 2007-06-22 | 2023-06-13 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US9044568B2 (en) | 2007-06-22 | 2015-06-02 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US10492855B2 (en) | 2007-09-26 | 2019-12-03 | Asahi Medical Technologies, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US20100256616A1 (en) * | 2007-09-26 | 2010-10-07 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US9283034B2 (en) | 2007-09-26 | 2016-03-15 | Retrovascular, Inc. | Recanalization system using radiofrequency energy |
US8911435B2 (en) | 2007-09-26 | 2014-12-16 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US9271787B2 (en) | 2007-09-26 | 2016-03-01 | Retrovascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US9849273B2 (en) | 2009-07-03 | 2017-12-26 | Ekos Corporation | Power parameters for ultrasonic catheter |
US8740835B2 (en) | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US9192566B2 (en) | 2010-02-17 | 2015-11-24 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US10888657B2 (en) | 2010-08-27 | 2021-01-12 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US9039702B2 (en) | 2010-11-16 | 2015-05-26 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10045817B2 (en) | 2010-11-16 | 2018-08-14 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US9017323B2 (en) | 2010-11-16 | 2015-04-28 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11051880B2 (en) | 2010-11-16 | 2021-07-06 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
WO2013013248A3 (en) * | 2011-07-20 | 2013-03-14 | Retrovascular, Inc. | Energy facilitated composition delivery |
WO2013013248A2 (en) * | 2011-07-20 | 2013-01-24 | Retrovascular, Inc. | Energy facilitated composition delivery |
US10869717B2 (en) | 2012-10-11 | 2020-12-22 | Tva Medical, Inc. | Devices and methods for fistula formation |
US9486276B2 (en) | 2012-10-11 | 2016-11-08 | Tva Medical, Inc. | Devices and methods for fistula formation |
US11707562B2 (en) | 2013-03-14 | 2023-07-25 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10821217B2 (en) | 2013-03-14 | 2020-11-03 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US9579494B2 (en) | 2013-03-14 | 2017-02-28 | Ekos Corporation | Method and apparatus for drug delivery to a target site |
US11219745B2 (en) | 2014-03-14 | 2022-01-11 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10695534B2 (en) | 2014-03-14 | 2020-06-30 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
US10646666B2 (en) | 2014-08-27 | 2020-05-12 | Tva Medical, Inc. | Cryolipolysis devices and methods therefor |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10507320B2 (en) | 2014-09-22 | 2019-12-17 | Ekos Corporation | Catheter system |
US11207070B2 (en) | 2015-02-09 | 2021-12-28 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US10603040B1 (en) | 2015-02-09 | 2020-03-31 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US11740138B2 (en) | 2015-06-10 | 2023-08-29 | Ekos Corporation | Ultrasound catheter |
US11826093B2 (en) | 2016-01-15 | 2023-11-28 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US10874422B2 (en) | 2016-01-15 | 2020-12-29 | Tva Medical, Inc. | Systems and methods for increasing blood flow |
US11026743B2 (en) | 2016-01-15 | 2021-06-08 | Tva Medical, Inc. | Devices and methods for forming a fistula |
US11590322B2 (en) | 2016-01-15 | 2023-02-28 | Tva Medical, Inc. | Devices and methods for advancing a wire |
US11285028B2 (en) | 2016-09-25 | 2022-03-29 | Tva Medical, Inc. | Vascular stent devices and methods |
US11769578B2 (en) | 2017-12-21 | 2023-09-26 | Sanofi | Transmission of data associated with an injection device usage using passive RF modulation |
US11865312B2 (en) | 2017-12-21 | 2024-01-09 | Sanofi | RFID dose tracking mechanism for injection devices |
CN111712280A (en) * | 2017-12-21 | 2020-09-25 | 赛诺菲 | Transmission of data relating to use of an injection device using passive RF modulation |
Also Published As
Publication number | Publication date |
---|---|
JP2017094092A (en) | 2017-06-01 |
KR20100075528A (en) | 2010-07-02 |
JP6461891B2 (en) | 2019-01-30 |
JP2019076741A (en) | 2019-05-23 |
CA2700968C (en) | 2019-06-11 |
CA3024053C (en) | 2021-12-07 |
EP2197383B1 (en) | 2018-01-31 |
WO2009042614A1 (en) | 2009-04-02 |
EP2197383A1 (en) | 2010-06-23 |
AU2008304599B2 (en) | 2012-11-22 |
JP5618332B2 (en) | 2014-11-05 |
EP3348221A1 (en) | 2018-07-18 |
CA3024053A1 (en) | 2009-04-02 |
JP6785832B2 (en) | 2020-11-18 |
KR101228879B1 (en) | 2013-02-05 |
US8911435B2 (en) | 2014-12-16 |
JP2014208263A (en) | 2014-11-06 |
EP2197383A4 (en) | 2012-08-22 |
AU2008304599A1 (en) | 2009-04-02 |
CA2700968A1 (en) | 2009-04-02 |
JP2010540099A (en) | 2010-12-24 |
JP6050283B2 (en) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8911435B2 (en) | Recanalizing occluded vessels using radiofrequency energy | |
US9283034B2 (en) | Recanalization system using radiofrequency energy | |
US10779884B2 (en) | Energy facilitated composition delivery | |
EP3209362B1 (en) | Redirecting delivery catheter | |
WO2013013248A2 (en) | Energy facilitated composition delivery | |
AU2011235882A1 (en) | Recanalizing occluded vessels using radiofrequency energy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: RETROVASCULAR, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KATOH, OSAMU;OGATA, WAYNE;REEL/FRAME:026689/0980 Effective date: 20100503 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551) Year of fee payment: 4 |
|
AS | Assignment |
Owner name: ASAHI MEDICAL TECHNOLOGIES, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:RETROVASCULAR, INC.;REEL/FRAME:048211/0124 Effective date: 20181203 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |